Harrow, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Harrow, Inc. (HROW) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $3.44 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-02
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.44M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.62M.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.80M.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.99M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $3.44M 10-K · filed 2026-03-02 |
| 2025-09-30 | $3.62M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.80M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $3.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $4.17M 10-K · filed 2025-03-27 |
| 2024-09-30 | $4.43M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.88M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $3.00M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.94M 10-K · filed 2024-03-19 |
| 2023-09-30 | $3.06M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.19M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.31M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.45M 10-K · filed 2023-03-23 |
| 2022-09-30 | $3.58M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.73M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.56B 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.44M 10-K · filed 2022-03-10 |
| 2021-09-30 | $2.62M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.70M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $2.92M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $3.03M 10-K · filed 2021-03-08 |
| 2020-09-30 | $3.16M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.41M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.51M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.62M 10-K · filed 2020-03-13 |
| 2019-09-30 | $2.59M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.69M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.80M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |